Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to ...
In a recent research paper uploaded to the bioRxiv preprint* server, researchers developed and tested novel bispecific antibodies (bsAbs) comprising both the N-terminal domain (NTD) and the receptor ...
How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...
Authors propose enhancing awareness of risks, close genomic surveillance and early diagnostic tests for symptomatic contacts as part of clinical management of these patients. *Please mention the ...
Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2. Study: AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results